Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 590Neoplasms 499Prostatic Neoplasms 316Lung Neoplasms 239Colorectal Neoplasms 201Motor Activity 134Carcinoma, Non-Small-Cell Lung 116Uterine Cervical Neoplasms 114Pancreatic Neoplasms 109Brain Neoplasms 109Head and Neck Neoplasms 104Stomach Neoplasms 100Rectal Neoplasms 98Carcinoma, Hepatocellular 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 68Esophageal Neoplasms 67Multiple Myeloma 65Hematologic Neoplasms 62Urinary Bladder Neoplasms 60Melanoma 59Sarcoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Glioblastoma 58Endometrial Neoplasms 57Glioma 53Anxiety Disorders 51Lymphoma 50Gastrointestinal Neoplasms 49

Interventions

Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Lipoma × Clear all
NCT06903208 2025-07-18

RFA for Superficial Lipomas

Columbia University

Phase NA Recruiting
10 enrolled

Cicatrix, Lipoma

NCT07014163 2025-06-10

Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas

Espad Pharmed

Phase NA Recruiting
10 enrolled

Lipoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡